![]() |
Volumn 13, Issue 2, 2014, Pages 102-
|
Anticancer drugs: Curbing self-renewal of cancer-initiating cells
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BMI1 PROTEIN;
MESSENGER RNA;
PTC 209;
SHORT HAIRPIN RNA;
UNCLASSIFIED DRUG;
CANCER CELL;
CANCER CELL CULTURE;
CANCER GRADING;
CANCER INHIBITION;
CANCER INITIATING CELL;
CANCER RECURRENCE;
CANCER RESISTANCE;
CANCER RISK;
CELL RENEWAL;
COLORECTAL CANCER;
DRUG MECHANISM;
HUMAN;
METASTASIS;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
RISK ASSESSMENT;
RISK FACTOR;
TUMOR GROWTH;
BMI1 GENE;
CANCER GROWTH;
CANCER STEM CELL;
COLORECTAL CANCER CELL LINE;
DOSE RESPONSE;
EPIGENETICS;
GENE EXPRESSION REGULATION;
GENE SILENCING;
GENE TARGETING;
IN VITRO STUDY;
IN VIVO STUDY;
SINGLE DRUG DOSE;
TUMOR XENOGRAFT;
ANIMALS;
COLORECTAL NEOPLASMS;
HETEROCYCLIC COMPOUNDS, 2-RING;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASTIC STEM CELLS;
POLYCOMB REPRESSIVE COMPLEX 1;
THIAZOLES;
|
EID: 84893222093
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4237 Document Type: Note |
Times cited : (1)
|
References (1)
|